OBJECTIVE: To assess the dose-response relationship (benefits and harms) of inhaled
corticosteroids (ICSs) in children with persistent asthma. METHODS: We conducted a …

Background Inhaled corticosteroids (ICS) are the first‐line treatment for children with
persistent asthma. Their potential for growth suppression remains a matter of concern for …

Background Treatment guidelines for asthma recommend inhaled corticosteroids (ICS) as
first‐line therapy for children with persistent asthma. Although ICS treatment is generally …

Background: Although inhaled corticosteroids (ICS) are commonly used in the treatment of
persistent asthma, the relationship between dose and clinical response remains unclear …

Abstract Background Inhaled corticosteroids (ICSs) are the mainstay of daily controller
treatment for persistent and uncontrolled asthma. However, many clinicians are wary of ICSs …

Because of their efficacy, inhaled corticosteroids (ICS) are the preferred first-line treatment
for children with persistent asthma of all ages [1]. Their potential for growth suppression in …

OBJECTIVE: To review pediatric trials of inhaled corticosteroid (ICS) therapy and summarize
data on the pediatric use of devices to facilitate delivery of ICSs. DATA SOURCES: Relevant …

Background Daily inhaled corticosteroids (ICS) are the recommended mainstay of treatment
in children and adults with persistent asthma. Yet often, ICS are used intermittently by …

Background Inhaled corticosteroids are recommended as first-line therapy for children with
mild persistent asthma; however, specific patient characteristics may modify the treatment …

Background Inhaled corticosteroids (ICS) are the most effective treatment for children with
persistent asthma. Although treatment with ICS is generally considered to be safe in …